Over recent years, massive improvements in sequencing productivity have led to a boom in DNA-based discovery that is rapidly translating to clinical and commercial application.
The Garvan Global Genomics Report is a deep dive into what this means for research, clinical practice, and global healthcare technologies. Via hundreds of tables and figures, the report examines trends in scientific discovery, clinical trials, and patenting activity relating to genomics.
It contains commentary on the business models of several hundred companies and supplies critical insights for institutions and companies trying to understand how to translate genomic discovery into clinical practice.
Supported by the Garvan Institute of Medical Research but prepared independently and objectively, this insightful and strategic report highlights the opportunities and risks for research institutions and emerging companies seeking to make their mark in this dynamic domain.
Genomics is creating new medical products and services